BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38786043)

  • 1. Elucidating the Role of MicroRNA-18a in Propelling a Hybrid Epithelial-Mesenchymal Phenotype and Driving Malignant Progression in ER-Negative Breast Cancer.
    Nair MG; Mavatkar AD; Naidu CM; V P S; C E A; Rajarajan S; Sahoo S; Mohan G; Jaikumar VS; Ramesh RS; B S S; Jolly MK; Maliekal TT; Prabhu JS
    Cells; 2024 May; 13(10):. PubMed ID: 38786043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-18a inhibits hypoxia-inducible factor 1α activity and lung metastasis in basal breast cancers.
    Krutilina R; Sun W; Sethuraman A; Brown M; Seagroves TN; Pfeffer LM; Ignatova T; Fan M
    Breast Cancer Res; 2014 Jul; 16(4):R78. PubMed ID: 25069832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SREBP1, targeted by miR-18a-5p, modulates epithelial-mesenchymal transition in breast cancer via forming a co-repressor complex with Snail and HDAC1/2.
    Zhang N; Zhang H; Liu Y; Su P; Zhang J; Wang X; Sun M; Chen B; Zhao W; Wang L; Wang H; Moran MS; Haffty BG; Yang Q
    Cell Death Differ; 2019 May; 26(5):843-859. PubMed ID: 29988076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-21 regulates epithelial-mesenchymal transition phenotype and hypoxia-inducible factor-1α expression in third-sphere forming breast cancer stem cell-like cells.
    Han M; Wang Y; Liu M; Bi X; Bao J; Zeng N; Zhu Z; Mo Z; Wu C; Chen X
    Cancer Sci; 2012 Jun; 103(6):1058-64. PubMed ID: 22435731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-18a activates Wnt pathway in ER-positive breast cancer and is associated with poor prognosis.
    Nair MG; Prabhu JS; Korlimarla A; Rajarajan S; P S H; Kaul R; Alexander A; Raghavan R; B S S; T S S
    Cancer Med; 2020 Aug; 9(15):5587-5597. PubMed ID: 32543775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Foxo3a-mediated overexpression of microRNA-622 suppresses tumor metastasis by repressing hypoxia-inducible factor-1α in ERK-responsive lung cancer.
    Cheng CW; Chen PM; Hsieh YH; Weng CC; Chang CW; Yao CC; Hu LY; Wu PE; Shen CY
    Oncotarget; 2015 Dec; 6(42):44222-38. PubMed ID: 26528854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer.
    Rhodes LV; Martin EC; Segar HC; Miller DF; Buechlein A; Rusch DB; Nephew KP; Burow ME; Collins-Burow BM
    Oncotarget; 2015 Jun; 6(18):16638-52. PubMed ID: 26062653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer.
    Gwak JM; Kim HJ; Kim EJ; Chung YR; Yun S; Seo AN; Lee HJ; Park SY
    Breast Cancer Res Treat; 2014 Aug; 147(1):39-49. PubMed ID: 25086633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-206 suppresses epithelial mesenchymal transition by targeting TGF-β signaling in estrogen receptor positive breast cancer cells.
    Yin K; Yin W; Wang Y; Zhou L; Liu Y; Yang G; Wang J; Lu J
    Oncotarget; 2016 Apr; 7(17):24537-48. PubMed ID: 27014911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen receptor beta as epigenetic mediator of miR-10b and miR-145 in mammary cancer.
    Piperigkou Z; Franchi M; Götte M; Karamanos NK
    Matrix Biol; 2017 Dec; 64():94-111. PubMed ID: 28797712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crocin inhibits the migration, invasion, and epithelial-mesenchymal transition of gastric cancer cells via miR-320/KLF5/HIF-1α signaling.
    Zhou Y; Xu Q; Shang J; Lu L; Chen G
    J Cell Physiol; 2019 Aug; 234(10):17876-17885. PubMed ID: 30851060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-655 suppresses epithelial-to-mesenchymal transition by targeting Prrx1 in triple-negative breast cancer.
    Lv ZD; Kong B; Liu XP; Jin LY; Dong Q; Li FN; Wang HB
    J Cell Mol Med; 2016 May; 20(5):864-73. PubMed ID: 26820102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer.
    Yu J; Xie F; Bao X; Chen W; Xu Q
    Mol Cancer; 2014 May; 13():121. PubMed ID: 24885626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipose derived stem cells promote tumor metastasis in breast Cancer cells by stem cell factor inhibition of miR20b.
    Xu H; Li W; Luo S; Yuan J; Hao L
    Cell Signal; 2019 Oct; 62():109350. PubMed ID: 31254605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiosensitizing effects of miR-18a-5p on lung cancer stem-like cells via downregulating both ATM and HIF-1α.
    Chen X; Wu L; Li D; Xu Y; Zhang L; Niu K; Kong R; Gu J; Xu Z; Chen Z; Sun J
    Cancer Med; 2018 Aug; 7(8):3834-3847. PubMed ID: 29860718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and biological impact of miR-18a expression in breast cancer after neoadjuvant chemotherapy.
    Luengo-Gil G; García-Martínez E; Chaves-Benito A; Conesa-Zamora P; Navarro-Manzano E; González-Billalabeitia E; García-Garre E; Martínez-Carrasco A; Vicente V; Ayala de la Peña F
    Cell Oncol (Dordr); 2019 Oct; 42(5):627-644. PubMed ID: 31115881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer.
    Lowery AJ; Miller N; Devaney A; McNeill RE; Davoren PA; Lemetre C; Benes V; Schmidt S; Blake J; Ball G; Kerin MJ
    Breast Cancer Res; 2009; 11(3):R27. PubMed ID: 19432961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA UCA1 enhances tamoxifen resistance in breast cancer cells through a miR-18a-HIF1α feedback regulatory loop.
    Li X; Wu Y; Liu A; Tang X
    Tumour Biol; 2016 Nov; 37(11):14733-14743. PubMed ID: 27629141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-410 Acts as a Tumor Suppressor in Estrogen Receptor-Positive Breast Cancer Cells by Directly Targeting ERLIN2 via the ERS Pathway.
    Wu H; Li J; Guo E; Luo S; Wang G
    Cell Physiol Biochem; 2018; 48(2):461-474. PubMed ID: 30016800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-34a and miR-200c Have an Additive Tumor-Suppressive Effect on Breast Cancer Cells and Patient Prognosis.
    Mansoori B; Silvestris N; Mohammadi A; Khaze V; Baghbani E; Mokhtarzadeh A; Shanehbandi D; Derakhshani A; Duijf PHG; Baradaran B
    Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33673143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.